Catherine Voegele

Centre international de recherche sur le cancer — France

Medicine · Health Sciences

24h-index2.1kcitations90works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nephrotoxicity and Medicinal Plants(17), Genetic factors in colorectal cancer(16), BRCA gene mutations in cancer(13), Neuroendocrine Tumor Research Advances(10), Cancer Genomics and Diagnostics(9)

Publications90 total

A clinically relevant morpho-molecular classification of lung neuroendocrine tumours
2025· 1 citedOpen Access
The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research
ESMO rare cancers.·2025· 2 citedOpen Access
<i>TERT</i> Expression and Clinical Outcome in Pulmonary Carcinoids
Journal of Clinical Oncology·2024· 10 citedOpen Access
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
ESMO Open·2024· 10 citedOpen Access
51O The European Prospective Investigation into Cancer and nutrition cohort (EPIC): A gateway to rare cancer epidemiological research – Insights from the EPIC Rare Cancers Working Group
ESMO Open·2024Open Access
Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms
GigaScience·2024· 11 citedOpen Access
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis
International Journal of Epidemiology·2023· 2 citedOpen Access
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Cancer Cell·2023· 69 citedOpen Access
Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms
2023· 2 citedOpen Access
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomisation analysis
2023· 1 citedOpen Access
Supplementary Table 1 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 3 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Data from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 3 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Data from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 1 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Figure 1 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 2 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Figure 1 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 2 from Rare Mutations in &lt;i&gt;RINT1&lt;/i&gt; Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Florence Le Calvez‐Kelm(28), James McKay(23), Matthieu Foll(23), Geoffroy Durand(18), Nicolas Alcala(16), Lynnette Fernandez‐Cuesta(15), Nathalie Forey(13), Lise Mangiante(12), Fabienne Lesueur(12), Maxime Vallée(11), Alexandra Sexton‐Oates(11), Tiffany M. Delhomme(10), Sean V. Tavtigian(10), Graham Byrnes(10), Francesca Damiola(10), Melissa C. Southey(9), Esther M. John(9), John L. Hopper(8), Irene L. Andrulis(8), Jules L. Derks(7)